JP2002531522A5 - - Google Patents

Download PDF

Info

Publication number
JP2002531522A5
JP2002531522A5 JP2000586362A JP2000586362A JP2002531522A5 JP 2002531522 A5 JP2002531522 A5 JP 2002531522A5 JP 2000586362 A JP2000586362 A JP 2000586362A JP 2000586362 A JP2000586362 A JP 2000586362A JP 2002531522 A5 JP2002531522 A5 JP 2002531522A5
Authority
JP
Japan
Prior art keywords
pcrv
composition
pseudomonas aeruginosa
antigen
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000586362A
Other languages
English (en)
Japanese (ja)
Other versions
JP4707234B2 (ja
JP2002531522A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/027796 external-priority patent/WO2000033872A2/en
Publication of JP2002531522A publication Critical patent/JP2002531522A/ja
Publication of JP2002531522A5 publication Critical patent/JP2002531522A5/ja
Application granted granted Critical
Publication of JP4707234B2 publication Critical patent/JP4707234B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000586362A 1998-11-25 1999-11-23 シュードモナスｖ抗原を用いる免疫化のための組成物 Expired - Fee Related JP4707234B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10995298P 1998-11-25 1998-11-25
US60/109,952 1998-11-25
US12679499P 1999-03-30 1999-03-30
US60/126,794 1999-03-30
PCT/US1999/027796 WO2000033872A2 (en) 1998-11-25 1999-11-23 Method of and compositions for immunization with the pseudomonas v antigen

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010273433A Division JP2011068672A (ja) 1998-11-25 2010-12-08 シュードモナス・アエルギノーザ感染を診断するための組成物

Publications (3)

Publication Number Publication Date
JP2002531522A JP2002531522A (ja) 2002-09-24
JP2002531522A5 true JP2002531522A5 (enExample) 2007-01-25
JP4707234B2 JP4707234B2 (ja) 2011-06-22

Family

ID=26807543

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000586362A Expired - Fee Related JP4707234B2 (ja) 1998-11-25 1999-11-23 シュードモナスｖ抗原を用いる免疫化のための組成物
JP2010273433A Ceased JP2011068672A (ja) 1998-11-25 2010-12-08 シュードモナス・アエルギノーザ感染を診断するための組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010273433A Ceased JP2011068672A (ja) 1998-11-25 2010-12-08 シュードモナス・アエルギノーザ感染を診断するための組成物

Country Status (10)

Country Link
US (2) US6309651B1 (enExample)
EP (2) EP1666058B1 (enExample)
JP (2) JP4707234B2 (enExample)
AT (2) ATE539349T1 (enExample)
AU (1) AU3580800A (enExample)
CA (1) CA2318536C (enExample)
DE (1) DE69930166T2 (enExample)
DK (1) DK1049488T3 (enExample)
ES (2) ES2255329T3 (enExample)
WO (1) WO2000033872A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002064161A2 (en) * 2001-01-26 2002-08-22 Mcw Research Foundation, Inc. Method and compositions for immunization with the pseudomonas v antigen
AU2007231760B2 (en) * 2001-01-26 2009-10-29 Mcw Research Foundation, Inc. Method and compositions for immunization with the pseudomonas V antigen
DE10294091D2 (de) * 2001-09-13 2004-08-05 Hannover Med Hochschule Phänotyp bestimmende Virulenzgene von Pseudomonas aeruginosa zur Kolonisation und Persistenz in Mensch, Tier und Pflanze, Verwendungen der Gene und zugehörigen Proteine
WO2003058205A2 (en) * 2002-01-11 2003-07-17 Cornell Research Foundation, Inc. Methods of identifying putative effector proteins
JP4630663B2 (ja) 2002-08-13 2011-02-09 ハプトゲン リミテッド 抗ラクトンシグナル分子抗体または抗ラクトン由来シグナル分子抗体による感染性細菌症の治療のための方法
EP2990053A1 (en) * 2004-01-20 2016-03-02 KaloBios Pharmaceuticals, Inc. Antibody specificity transfer using minimal essential binding determinants
GB0407008D0 (en) 2004-03-27 2004-04-28 Haptogen Ltd Methods for inducing rapid cell death (autolysis) in infectious bacteria
GB0410958D0 (en) 2004-05-15 2004-06-16 Haptogen Ltd Methods for reducing biofilm formation in infectious bacteria
JPWO2007049770A1 (ja) 2005-10-28 2009-04-30 明治製菓株式会社 緑膿菌の外膜タンパク質ｐａ５１５８
JPWO2007114340A1 (ja) 2006-03-30 2009-08-20 明治製菓株式会社 緑膿菌の外膜タンパク質ｐａ０４２７
SG182975A1 (en) * 2007-06-29 2012-08-30 Meiji Seika Kaisha Pseudomonas aeruginosa outer membrane protein pa4710
CA2706732A1 (en) * 2007-11-30 2009-06-11 Kalobios Pharmaceuticals, Inc. Antibodies to the pcrv antigen of pseudomonas aeruginosa
EP2236515A4 (en) 2007-12-25 2012-10-31 Meiji Seika Kaisha COMPONENT PROTEIN PA1698 FOR PSEUDOMONAS AERUGINOSA TYPE-III SECRETION SYSTEM
WO2009088032A1 (ja) * 2008-01-10 2009-07-16 Shionogi & Co., Ltd. ＰｃｒＶに対する抗体
CA2751433A1 (en) 2009-02-04 2010-08-12 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
CN102341496B (zh) 2009-03-11 2014-07-02 盐野义制药株式会社 具有抗绿脓杆菌作用的人源化PcrV抗体
JP2013515079A (ja) * 2009-12-22 2013-05-02 カロバイオス ファーマシューティカルズ インコーポレイティッド 低レベルの病原性シュードモナス・エルギノーサ（Ｐｓｅｕｄｏｍｏｎａｓａｅｒｕｇｉｎｏｓａ）感染症を有する患者のスタフィロコッカス（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ）感染症を治療する方法
JP6293659B2 (ja) * 2011-07-01 2018-03-14 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 抗プロペルジン抗体およびその使用
HUE050985T2 (hu) 2011-11-07 2021-01-28 Medimmune Ltd Pseudomonas PSL és PCRV elleni kötõmolekulát alkalmazó kombinációs terápiák
CN104870474B (zh) 2012-10-04 2019-03-12 诺沃姆德治疗公司 用于治疗溶血性疾病的旁路途径特异性抗体
CN110028559B (zh) * 2019-04-15 2022-06-10 中国人民解放军陆军军医大学 一种铜绿假单胞菌疫苗重组蛋白及其编码基因和它们的应用
US20220378902A1 (en) * 2019-08-22 2022-12-01 Sichuan University Bacterial membrane vesicles, and separation and preparation system and method therefor
EP4069312A4 (en) * 2019-12-04 2024-03-27 The Research Foundation for the State University of New York COMPOSITIONS AND METHODS FOR REDUCING OFF-TARGET TOXICITY OF ANTIBODY-DRUG CONJUGATES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3178014B2 (ja) * 1991-07-05 2001-06-18 東ソー株式会社 Ｒｎａの測定方法
US5599665A (en) 1993-12-21 1997-02-04 Mcw Research Foundation Pseudomonas aeruginosa nucleic acids encoding exoenzyme S activity and use thereof in detecting pseudomonas aeruginosa infection

Similar Documents

Publication Publication Date Title
JP2002531522A5 (enExample)
CA2318536A1 (en) Method of and compositions for immunization with the pseudomonas v antigen
JP2004511201A5 (enExample)
JP2010532657A5 (enExample)
WO2001070174A8 (en) Vegf-modulated genes and methods employing them
WO2001021810B1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
JPH07504565A (ja) ワクチンおよび診断に有用なＨｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉタンパク質
JP2002272489A5 (enExample)
WO2000066739A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
JPH07506573A (ja) プロテインｌおよびそのハイブリッドプロテイン類
WO2001021804B1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
EP0826774A3 (en) Staphylococcal Fab I enoyl-ACP reductase
CA2195090A1 (en) Lkp pilin structural genes and operon of nontypable haemophilus influenzae
AU2005203173B2 (en) Super-antigen fusion proteins and the use thereof
EP2172214A3 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
CA2190359A1 (en) Nucleic acids of rochalimaea henselae and rochalimaea quintana and methods and compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection
WO2001046226A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
CA2323751A1 (en) Diagnostics and vaccines for mycobacterial infections of animals and humans
EP1749833A1 (en) Super-antigens derived from the SARS coronavirus E2 spike protein
ATE435915T1 (de) Spezifische nukleinsäuren und polypeptide aus krankheitserregenden stämmen von neisseria
WO2000006742A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
JP2002514891A (ja) ヘリコバクター・ピロリからの分泌性遺伝子を同定する方法
CN1318646A (zh) 编码伤寒沙门氏菌特异性和抗原性外膜蛋白的dna序列
WO1998004585A3 (en) Novel human macrophage antigen
CN101525378A (zh) 鳗利斯顿氏菌亚单位疫苗抗原蛋白与应用